SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011853
Filing Date
2018-05-08
Accepted
2018-05-08 16:24:37
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbay-10q_20180331.htm 10-Q 1504686
2 EX-10.1 cbay-ex101_90.htm EX-10.1 121442
3 EX-31.1 cbay-ex311_9.htm EX-31.1 15430
4 EX-31.2 cbay-ex312_10.htm EX-31.2 15335
5 EX-32.1 cbay-ex321_11.htm EX-32.1 8007
6 GRAPHIC g201805081856040882353.jpg GRAPHIC 40245
7 GRAPHIC g201805081856001782352.jpg GRAPHIC 35086
  Complete submission text file 0001564590-18-011853.txt   6659510

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cbay-20180331.xml EX-101.INS 1753439
9 XBRL TAXONOMY EXTENSION SCHEMA cbay-20180331.xsd EX-101.SCH 37879
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20180331_cal.xml EX-101.CAL 35986
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20180331_def.xml EX-101.DEF 108344
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20180331_lab.xml EX-101.LAB 287630
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20180331_pre.xml EX-101.PRE 215486
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 18814973
SIC: 2834 Pharmaceutical Preparations